SCHEMBL2294814

SCHEMBL2294814

CCCc1ccc(OCc2ccc(C(=O)Nc3ccccc3C(=O)OC)cc2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SENP7 Q9BQF6 2/20 0.74
▸ SENP8 Q96LD8 1/20 0.74
▸ SENP6 Q9GZR1 1/20 0.74
▸ SMN1; SMN2 Q16637 3/20 0.72
▸ MAPT P10636 2/20 0.72
▸ POLB P06746 1/20 0.72
▸ KDM4E B2RXH2 3/20 0.66
▸ HPGD P15428 2/20 0.66
▸ ALDH1A1 P00352 1/20 0.66
▸ ABCG2 Q9UNQ0 3/20 0.66
▸ TSHR P16473 3/20 0.57
▸ HSD17B10 Q99714 2/20 0.57
▸ LMNA P02545 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ CYP2D6 P10635 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ NPC1 O15118 2/20 0.57
▸ RAB9A P51151 2/20 0.57
▸ MEN1 O00255 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2291513 0.89 KDM4E (0.69) SENP7SENP8SENP6SMN1; SMN2MAPT
SCHEMBL2290505 0.87 KDM4E (0.67) SENP7SENP8SENP6SMN1; SMN2MAPT
SCHEMBL2291128 0.86 KDM4E (0.66) SENP7SENP8SENP6SMN1; SMN2MAPT
SCHEMBL6338190 0.86 KDM4E (0.66) SENP7SENP8SENP6SMN1; SMN2MAPT
SCHEMBL19831686 0.85 SENP7 (0.79) SENP7SENP8SENP6SMN1; SMN2ABCG2
SCHEMBL13719210 0.83 TSHR (0.72) SMN1; SMN2MAPTPOLBKDM4EHPGD
SCHEMBL2291530 0.82 KDM4E (0.69) SMN1; SMN2MAPTPOLBKDM4EHPGD
SCHEMBL9369169 0.81 RAB9A (0.74) SENP7SENP8SENP6SMN1; SMN2MAPT
SCHEMBL10582250 0.81 TSHR (0.65) SMN1; SMN2MAPTPOLBKDM4EHPGD
SCHEMBL2292344 0.80 KDM4E (0.74) SENP7SMN1; SMN2MAPTKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247637-A1 Novel Anthranilic Acid Derivatives DEHMLOW HENRIETTA 2009-10-01 — — US claimed
JP-2008546661-A — — 2008-12-25 — — JP claimed
EP-1896396-A1 ANTHRANILIC ACID DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-03-12 — — EP claimed
WO-2006134040-A1 ANTHRANILIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-12-21 — — WO claimed
US-20060281810-A1 Novel anthranilic acid derivatives HOFFMANN-LA ROCHE INC. 2006-12-14 — — US claimed
US-7989657-B2 Anthranilic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2011-08-02 — — US disclosed
US-20090247637-A1 Novel Anthranilic Acid Derivatives DEHMLOW HENRIETTA 2009-10-01 — — US disclosed
EP-1896396-A1 ANTHRANILIC ACID DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-03-12 — — EP disclosed
WO-2006134040-A1 ANTHRANILIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-12-21 — — WO disclosed
US-20060281810-A1 Novel anthranilic acid derivatives HOFFMANN-LA ROCHE INC. 2006-12-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060281810-A1 Novel anthranilic acid derivatives GPR84, HCAR1, GPR88 SENP7 3389/4885SENP8 4124/4885SENP6 3752/4885
US-20090247637-A1 Novel Anthranilic Acid Derivatives GPR84, GPR88, HCAR1 SENP7 3115/4885SENP8 4088/4885SENP6 3684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback